| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/24/2008 | WO2008047914A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | WO2008047723A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | WO2008047486A1 Myocardial injury-controlling agent |
| 04/24/2008 | WO2008047473A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | WO2008047235A2 Methods of treating disorders associated with fat storage |
| 04/24/2008 | WO2008047023A2 Immunisation method against the 4 dengue serotypes |
| 04/24/2008 | WO2008046724A1 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 04/24/2008 | WO2008046650A1 Novel method for treating h.pylori infections |
| 04/24/2008 | WO2008046615A2 Anti-ige vaccines |
| 04/24/2008 | WO2008046576A1 Use of glucocorticoid antagonists in vaccination |
| 04/24/2008 | WO2008046529A1 Treatment of chemotherapy- or radiotherapy-resistant tumors using an l1 interfering molecule |
| 04/24/2008 | WO2008046459A1 Treatment of chemotherapy- or radiotherapy-resistant tumors using an l1 interfering molecule |
| 04/24/2008 | WO2008030931A3 Methods of treating tendonitis in a subject by using an anti-cytokine agent |
| 04/24/2008 | WO2008021263A3 Methods of indentifying antibodies that bind oligomeric forms of chemokines and uses thereof |
| 04/24/2008 | WO2008012693A3 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy |
| 04/24/2008 | WO2007149935A3 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 04/24/2008 | WO2007143168A3 High affinity antibodies to human il-6 receptor |
| 04/24/2008 | WO2007112703A3 Pharmaceutical composition containing the nmb0606 protein |
| 04/24/2008 | WO2007065014A3 Methods and compositions to increase immune function |
| 04/24/2008 | US20080098490 Recombinant animal for use as bioreactor in production of human immunoglobulins |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096822 Use of the Neurotoxic Component of a Botulinum Toxin |
| 04/24/2008 | US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease |
| 04/24/2008 | US20080096808 co-administering the protein replacement therapy with rapamycin, to inhibiting the immune response of a host to protein replacement therapy; immunology modulators |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080095857 avidin-modified protein-based nanoparticles to which biotinylated antibodies are bound by forming a stable avidin-biotin complex; preferably human serum albumin is used as protein |
| 04/24/2008 | US20080095854 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095826 Method of Increasing Peripheral Blood Lymphocytes |
| 04/24/2008 | US20080095805 Method Of Detecting Cancer Based On Immune Reaction To Boris |
| 04/24/2008 | US20080095804 Two-step immunization procedure against chlamydia infection |
| 04/24/2008 | US20080095803 Protein matrix vaccines and methods of making and administering such vaccines |
| 04/24/2008 | US20080095801 Containing Ledum palustre (marsh tea or wild rosemary), in form of homeopathic dilution in inert carrier material and at least one secretion from a parasite, a sufferer of disease caused by parasites, or from an intermediate host, in form of homeopathic dilution in inert carrier; for ticks, mosquitoes |
| 04/24/2008 | US20080095800 Eliciting HCV-specific antibodies |
| 04/24/2008 | US20080095799 Apparatus for vaccine development using ultrasound technology |
| 04/24/2008 | US20080095798 Ii-key enhanced vaccine potency |
| 04/24/2008 | US20080095797 Marek's disease virus having a mutation in one or both Meq genes thereof such that the virus is non-pathogenic; vaccines; for prevention or treatment of Marek's disease in poultry |
| 04/24/2008 | US20080095796 IBD virus TY2 strain or a passage strain of said viral strain allows for production of a vaccine that is efficacious to IBD variant viral strains that may have new properties not protectable by the conventional vaccines |
| 04/24/2008 | US20080095795 Use of iscom particle(s) as adjuvant in a formulation of vaccine antigens, which comprise at least one iscom-iscom matrix particle together with a non-replicating vaccine antigen and one or more living micro-organisms; enhanced immune response against live vaccine components |
| 04/24/2008 | US20080095794 Recombinant bcg strains with enhanced ability to escape the endosome |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095792 Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus |
| 04/24/2008 | US20080095791 Nucleotide sequences coding human immunodeficiency viral envelope protein fusion comprising epitopes from three viral variants for use in developing antibodies to prevent viral infection |
| 04/24/2008 | US20080095790 Methods of Treating Prostate Cancer |
| 04/24/2008 | US20080095789 Vaccine |
| 04/24/2008 | US20080095788 Vaccines |
| 04/24/2008 | US20080095787 Adjuvants and methods of use |
| 04/24/2008 | US20080095786 Compositions And Methods For Preventing And Treating Endotoxin-Related Diseases And Conditions |
| 04/24/2008 | US20080095785 Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
| 04/24/2008 | US20080095784 Monospecific immunoglobulin for treating autoimmune, cell proliferative and transplant rejection disorders |
| 04/24/2008 | US20080095783 Monoclonal antibody specific to Lewis Y antigen for enhancing antibody dependent cell-mediated cytotoxicity and treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 04/24/2008 | US20080095782 Using secreted glycoprotein (Lipocalin-2) for treatment of obesity and as evaluative tool in detection of glucose tolerance, insulin resistance and Type 2 diabetes in mammals |
| 04/24/2008 | US20080095781 Agonist antibody specific for death receptor-4 (DR4)polypeptide for use in treatment and prevention of infection, nervous system, cell proliferative and autoimmune disorders |
| 04/24/2008 | US20080095780 Binding Molecules For Treatment And Detection Of Cancer |
| 04/24/2008 | US20080095779 Using modulators which alter protein DNA binding as tool in prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080095778 Treatment Of Fungal Infections |
| 04/24/2008 | US20080095777 Immunogenic Composition for Use in Vaccination Against Staphylococcei |
| 04/24/2008 | US20080095776 Erythropoietin receptor binding antibodies |
| 04/24/2008 | US20080095775 Immunoglobulin for use in prevention and treatment of diabetes, arthritis, autoimmune, skin, respiratory and inflammatory disorders; immunotherapy |
| 04/24/2008 | US20080095774 Agents and Methods for Specifically Blocking CD28-Mediated Signaling |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095772 Antibodies against human parathyroid hormone related protein |
| 04/24/2008 | US20080095771 Treatment Method |
| 04/24/2008 | US20080095770 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 04/24/2008 | US20080095769 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 04/24/2008 | US20080095768 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 04/24/2008 | US20080095767 Engineered antibodies with new world primate framework regions |
| 04/24/2008 | US20080095766 Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity |
| 04/24/2008 | US20080095765 IL-5R-specific antibody composition |
| 04/24/2008 | US20080095764 Use of genetically-and epigenetically-altered protocadherins in methods of diagnosing, prognosing, and treating cancer |
| 04/24/2008 | US20080095763 Using cyclin dependent kinase -9 (CDK9) as diagnostic tool in identifying modulators of insulin like growth factor function; antitumor agents; antihypoxic agents |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095761 Using steroid alkaloid cyclopamine to treat and prevent tumor progression in urogenital system |
| 04/24/2008 | US20080095747 Promotion of Cell Migration and Axon Regeneration in the Cns |
| 04/24/2008 | US20080095746 Using cells expressing podocalyxin-like protein 1 (PCLP1) as source for propagating progenitor cells for use in treatment of blood and vascular diseases; regenerative medicine |
| 04/24/2008 | US20080095744 Using conditionally replicative herpes viral vector comprising cytokine sequences to transform cells and activate immune response from CD4, CD8 and natural killer cells towards aberrently proliferating cells; immunotherapy |
| 04/24/2008 | US20080095738 Vlp-Antigen Conjugates and Their Uses as Vaccines |
| 04/24/2008 | US20080095703 Method For Checking And Controlling The Mammalian Lactic Acid Fermentation Process / Aerobic Glucose Fermentation Metabolic Pathway In Mammalian Organism |
| 04/24/2008 | US20080095700 DR4 antibodies and uses thereof |
| 04/24/2008 | US20080095699 Imaging contrast agents using nanoparticles |
| 04/24/2008 | CA2669290A1 Salmonella based oral vaccines for anthrax |
| 04/24/2008 | CA2667067A1 Antibody antagonists of interleukin-13 receptor .alpha.1 |
| 04/24/2008 | CA2667030A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | CA2666934A1 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| 04/24/2008 | CA2666859A1 Novel method for treating h.pylori infections |
| 04/24/2008 | CA2666843A1 Treatment of age-related macular degeneration and other diseases of the eye |
| 04/24/2008 | CA2666809A1 Anti-cancer agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666613A1 Methods of treating disorders associated with fat storage |
| 04/24/2008 | CA2666559A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666458A1 Antibody molecules which bind il-17a and il-17f |
| 04/24/2008 | CA2665534A1 Antibodies that bind cxcr7 epitopes |
| 04/24/2008 | CA2665528A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | CA2663885A1 Immunisation method against the 4 dengue serotypes |
| 04/24/2008 | CA2663561A1 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 04/23/2008 | EP1914312A2 Virulence genes and proteins, and their use |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |